ER-Positive, HER2-Positive Metastatic Breast Cancer — Patterns of Care Among Community Oncologists

Featuring perspectives from Dr Lisa A Carey and Dr Maha Hussain, including the following topics:

Introduction (0:00)
HER2 History (1:32)
Cases from the GMO Survey (7:06)
Biology and Selection of First-Line Therapy for HR-Positive, HER2-Positive Metastatic Breast Cancer (mBC) — Dr Mahtani (19:56)
Faculty Case Presentations (31:37)
Patterns of Care Survey — Part 1 (38:26)
Optimizing the Use of Up-Front Maintenance Therapy for HER2-Positive mBC — Dr Carey (44:53)
Faculty Case Presentations (54:13)